NCT01948297 2020-09-09Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) AlterationsDebiopharm International SAPhase 1 Terminated77 enrolled
NCT00695448 2017-07-25Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or LymphomaGlaxoSmithKlinePhase 1 Terminated11 enrolled
NCT00497679 2009-05-14AZD1152 in Patients With Advanced Solid Malignancies-Study 3AstraZenecaPhase 1 Terminated45 enrolled